Lurker Nancy

Director at COLL; Director at EYPT; Director at AUXILIUM PHARMACEUTICALS INC

Sold, on record
$2.9M
Dollars the filings state
Form 4 sales
7
Latest May 13, 2026
Form 144 notices
3
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice EYPTNotice
    Dec 4, 2023 2023

    Filed to sell 20,000 shares ($415k)

    Lurker Nancy, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale EYPTRoutine
    Dec 4, 2023 same day

    Sold 20,000 shares at $20.76 ($415k)

    Lurker Nancy, Executive Vice Chair

    10b5-1 planSold 10.5% of holdings ($4M position)170,559 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice EYPTNotice
    Jan 23, 2024 +50 days

    Filed to sell 5,044 shares ($126k)

    Lurker Nancy, Director

    10b5-1 planFiling

  4. 4 Form 144 notice EYPTNotice
    Jan 24, 2024 +1 day

    Filed to sell 29,956 shares ($748k)

    Lurker Nancy, Director

    10b5-1 planFiling

  5. 5 Form 4 sale EYPTRoutine
    Jan 24, 2024 same day

    Sold 35,000 shares at $24.98 ($874k)

    Lurker Nancy, Executive Vice Chair

    10b5-1 planSold 20.5% of holdings ($4.3M position)135,441 shares leftFollows a Form 144Filing

  6. 6 Form 4 sale EYPTRoutine
    Nov 28, 2025 +674 days

    Sold 700 shares at $14.95 ($10k)

    Lurker Nancy, Director

    10b5-1 planSold 0.3% of holdings ($3.2M position)215,847 shares leftFiling

  7. 7 Form 4 sale EYPTRoutine
    Dec 4, 2025 +6 days

    Sold 9,300 shares at $15.11 ($141k)

    Lurker Nancy, Director

    10b5-1 planSold 4.3% of holdings ($3.3M position)206,547 shares leftFiling

  8. 8 Form 4 sale COLLNo plan
    May 13, 2026 +160 days

    Sold 4,500 shares at $35.97 ($162k)

    Lurker Nancy, Director

    No 10b5-1 planSold 20% of holdings ($810k position)18,017 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Lurker Nancy
Source
May 13, 2026May 15, 2026COLLDirectorForm 4 sale4,500$162k20.0%No planSEC
Dec 4, 2025Dec 5, 2025EYPTDirectorForm 4 sale9,300$141k4.3%RoutineSEC
Nov 28, 2025Dec 1, 2025EYPTDirectorForm 4 sale700$10k0.3%RoutineSEC
Jan 24, 2024Jan 25, 2024EYPTExecutive Vice ChairForm 4 sale35,000$874k20.5%RoutineSEC
Jan 24, 2024Jan 24, 2024EYPTDirectorForm 144 notice29,956$748kNoticeSEC
Jan 23, 2024Jan 23, 2024EYPTDirectorForm 144 notice5,044$126kNoticeSEC
Dec 4, 2023Dec 6, 2023EYPTExecutive Vice ChairForm 4 sale20,000$415k10.5%RoutineSEC
Dec 4, 2023Dec 4, 2023EYPTDirectorForm 144 notice20,000$415kNoticeSEC
Nov 15, 2021Nov 17, 2021EYPTPresident & CEOForm 4 sale10,000$202k8.8%Plan not statedSEC
Dec 5, 2014Dec 8, 2014AUXILIUM PHARMACEUTICALS INCDirectorForm 4 sale32,430$1.1M76.4%UnusualSEC